TickerSparkInvestor Intelligence
Spark Generator
Stock Deep Dives
AI Analyst
Agentic Chat
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Spark Charts
AI Technical Analysis
The Feed
Today's Market Intel
Stock Reports
AI Research Reports
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
PlansLaunch App
Log inGet Started
TickerSpark Feed

BIIB Coverage

Every TickerSpark article mentioning BIIB — research reports, earnings, trending movements, and macro context.

2 articles

Biogen (BIIB): Turnaround Gains Traction as Growth Mix Improves
Research ReportBIIB

Biogen (BIIB): Turnaround Gains Traction as Growth Mix Improves

Biogen is no longer just a declining MS story. Q1 2026 showed rising EPS, stronger free cash flow, and growing newer products, but full-year revenue still faces pressure.

May 14, 2026·24 min read
HealthcareDrug Manufacturers - GeneralBiotech
Biogen Inc. (BIIB) drops 6% after mixed Alzheimer’s data
Trending StockBIIB

Biogen Inc. (BIIB) drops 6% after mixed Alzheimer’s data

Biogen Inc. (BIIB) drops sharply after mixed Phase 2 Alzheimer’s trial results for diranersen, also known as BIIB080. The stock fell on heavy volume as investors focused on the missed primary endpoint, even though the study showed encouraging biomarker and cognitive signals and the program may still advance.

May 14, 2026·7 min read

Want a deeper dive on BIIB?

Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.

Generate BIIB Report
TickerSpark

Institutional-grade market intelligence for the retail investor. Stop guessing. Start winning.

Product

  • Spark Generator
  • AI Analyst
  • Plans

Research

  • The Feed
  • Stock Reports
  • Macro Updates
  • Blog

Company

  • About Us
  • Contact

Legal

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC. All rights reserved.

Made in Delaware, USA.